SCHEMBL19488484

SCHEMBL19488484

C#Cc1ccc2c(ccc3nc(CN(CCC)C(=O)OC(C)(C)C)[nH]c32)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRA6 Q16445 2/20 0.36
GABRA3 P34903 1/20 0.36
GABRA4 P48169 1/20 0.36
CACNA1G O43497 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNA1C Q13936 1/20 0.33
ALDH1A1 P00352 2/20 0.32
USP2 O75604 2/20 0.32
LMNA P02545 1/20 0.32
PIM1 P11309 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
NLRP3 Q96P20 2/20 0.31
HDAC1 Q13547 2/20 0.31
SCN9A Q15858 1/20 0.31
HDAC3 O15379 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19488790 0.95 GABRA1 (0.35) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL19488483 0.90 GABRA1 (0.34) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL19488782 0.88 GABRA1 (0.36) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL19883604 0.86 LMNA (0.37) CACNA1GCACNA1BCACNA1CALDH1A1USP2
SCHEMBL19339742 0.86 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL10202452 0.84 GABRA1 (0.41) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL19488780 0.78 GABRA1 (0.33) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL19339591 0.73 HDAC3 (0.43) CACNA1GCACNA1BCACNA1CALDH1A1HDAC1
SCHEMBL18526454 0.72 GABRA1 (0.37) GABRA1GABRG2GABRB3GABRA5GABRA2
SCHEMBL19488865 0.72 LMNA (0.37) ALDH1A1USP2LMNAHDAC1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601188-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-10-18 EP disclosed